| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |